Beijing: One of the leading vaccines in the world made by China’s Sinopharm has reportedly been administered to lakhs of people.
The vaccine comes in two-doses and it is reported that none of the recipients developed an adverse reaction or infection.
The vaccine has been administered under an emergency-use programme and is being tested on frontline workers. Pregnant and breast-feeding women are not being given the vaccine.
The state-run company has invested over 2 billion USD for the vaccine and is currently carrying Phase 3 testing in the Middle-East and South Africa, apart from China. The vaccine is based on an inactive coronavirus. The Oxford vaccine, which recently hit a roadblock after a volunteer develops an unexplained illness, is based on Chimpanzee adenovirus.
Sinopharm’s vaccine is expected to hit the market by the end of the year if everything goes right.
Comments are closed.